Osivax
Developing pan-respiratory virus vaccines
- B2B
About Osivax
A clinical-stage biopharmaceutical company leveraging self-assembling nanoparticle technology to develop transformative respiratory virus vaccines with superior immune responses
Key facts
- Industry
- Biotechnology Research
- Company size
- 51–250 employees
- Headquarters
- Lyon, Auvergne-Rhône-Alpes, France
- Founded
- 2017
- Revenue
- $9M – $71.3MTamtam estimate
- Website
- osivax.com
- linkedin.com/company/osivax
Osivax at a glance
Osivax is a B2B company in the Biotechnology Research industry, headquartered in Lyon, Auvergne-Rhône-Alpes, France.
Osivax was founded in 2017.
Osivax has 51–250 employees.
Osivax's revenue is $9M – $71.3M (Tamtam estimate).
Selling to companies like Osivax?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies